Marly D. van den Boom

The Netherlands Cancer Institute — Netherlands

Medicine · Health Sciences

7h-index630citations8works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(6), Immunotherapy and Immune Responses(5), T-cell and B-cell Immunology(3), Virus-based gene therapy research(3), Immune Cell Function and Interaction(2)

Publications8 total

Requirements for Effective Antitumor Responses of TCR Transduced T Cells
The Journal of Immunology·2008· 54 citedOpen Access
TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation
The Journal of Immunology·2008· 41 citedOpen Access
In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity
The Journal of Immunology·2007· 43 citedOpen Access
Generation of T Cell Help through a MHC Class I-Restricted TCR
The Journal of Immunology·2006· 45 citedOpen Access
Targeting self-antigens through allogeneic TCR gene transfer
Blood·2006· 72 citedOpen Access
Immunotherapy through TCR gene transfer
Nature Immunology·2001· 277 cited
Changing T cell specificity by retroviral T cell receptor display
Proceedings of the National Academy of Sciences·2000· 94 citedOpen Access
Tumor burden impairment of murine natural killer cell cytotoxicity.
PubMed·1988· 4 cited

Frequent Co-authors

Ton N. Schumacher(7), Helmut W. Kessels(3), Monika C. Wolkers(3), Moniek A. de Witte(3), John B.A.G. Haanen(3), Miriam Coccoris(2), Elly Mesman(2), Gavin Bendle(2), Martin A. van den Valk(1), Hergen Spits(1), Erik Hooijberg(1), Ji‐Ying Song(1), Martin van der Valk(1), Annelies Jorritsma(1), Andrew Kaiser(1), Maarten Dokter(1), Koen Schepers(1), David J. Topham(1), Adriaan D. Bins(1), Todd D. Schell(1)